Synopsis of recent research by authors named "Xiangqing Ren"
Xiangqing Ren's research primarily focuses on the interactions between tumor microenvironments, immune regulation, and novel therapeutic targets, particularly in the context of gastrointestinal cancers and hepatocellular carcinoma.
Recent studies explore the significance of the CD39-CD73-eAdo/A2aR axis in immunotherapy responses and the potential of epigenetic modifications like N6-methyladenosine in cancer progression.
Additionally, Ren has developed predictive models for treatment outcomes in advanced gastric adenocarcinoma and investigated the prognostic implications of specific genes and immune infiltration in various cancers.
